Confessions of an Ex-Fly Pusher

Two decades ago, I sat at Herman J. Muller's desk at Indiana University, pushing flies as he once did. Looking back in light of the recent unveiling of the Drosophila melanogaster genome sequence,1 I realize that I was struggling in the Dark Ages of genetics, when we worked by inference rather than scanning databases of A,T, C, and G. If I labored in the Dark Ages, then Thomas Kaufman, my mentor, received his training in the Stone Age; Muller was positively Precambrian. Back in the 1970s,

Written byRicki Lewis
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Two decades ago, I sat at Herman J. Muller's desk at Indiana University, pushing flies as he once did. Looking back in light of the recent unveiling of the Drosophila melanogaster genome sequence,1 I realize that I was struggling in the Dark Ages of genetics, when we worked by inference rather than scanning databases of A,T, C, and G. If I labored in the Dark Ages, then Thomas Kaufman, my mentor, received his training in the Stone Age; Muller was positively Precambrian.

Back in the 1970s, we would routinely drive fly larvae to a children's cancer treatment center in Indianapolis to zap them with X-rays, or we'd expose larvae to chemical mutagens. Weeks later, we'd scrutinize the next generation for the errant bristle pattern or missing, extra, or misplaced part that would indicate mutation, the only way we had then to reveal normal function. Further matings would define genes and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies